Meconium aspiration syndrome (MAS) in the newborn – delivery-room & ongoing management
Meconium-stained respiratory failure · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
MAS is respiratory distress in a meconium-stained infant with characteristic chest radiograph changes, caused by airway obstruction, chemical pneumonitis, surfactant inactivation and often pulmonary hypertension. Routine intrapartum/oropharyngeal suctioning and routine tracheal suction of vigorous babies are NOT recommended; management is supportive with escalation as needed.
Red flags
- Rapid desaturation suggesting pneumothorax
- Large pre/post-ductal SpO2 gradient indicating PPHN
- Rising oxygenation index despite optimal ventilation
- Refractory hypotension or shock
- Persistent acidosis or lactataemia
Assessment
Differential diagnosis
- Transient tachypnoea of the newborn
- Respiratory distress syndrome (if preterm)
- Congenital/early-onset pneumonia or sepsis
- Persistent pulmonary hypertension of the newborn
- Pneumothorax or air leak
- Congenital heart disease
Investigations
- Chest radiograph (patchy asymmetric infiltrates, hyperinflation, air leaks)
- Arterial blood gas and pre/post-ductal SpO2
- Full blood count, CRP and blood culture
- Blood glucose, electrolytes and lactate
- Echocardiography if PPHN suspected or oxygenation poor
- Oxygenation index trending if ventilated
Management
- At birth, follow standard NLS/NRP: if the baby is vigorous, do NOT perform tracheal suction – dry, stimulate and assess.
- If the baby is non-vigorous (apnoeic/poor tone) and not responding, prioritise effective ventilation; consider direct laryngoscopy and tracheal suction only if the airway is obstructed, without delaying ventilation.
- Provide supplemental oxygen titrated to targeted pre-ductal SpO2; avoid both hypoxia and hyperoxia.
- Admit to NICU for continuous monitoring; obtain chest radiograph and blood gas.
- Support breathing: CPAP for moderate distress; intubate and ventilate for respiratory failure, using strategies that minimise barotrauma given air-leak risk.
- Maintain adequate mean airway pressure/lung recruitment; consider gentle ventilation or HFOV for severe disease.
- Give surfactant for significant parenchymal disease/oxygenation failure; consider surfactant lavage in refractory cases.
- Start empirical antibiotics after cultures because pneumonia cannot be excluded.
- Screen for and treat PPHN (pre/post-ductal gradient, echocardiography) with inhaled nitric oxide if indicated.
- Maintain normal temperature, glucose, calcium, systemic BP and adequate sedation/analgesia.
- Watch closely for pneumothorax; have equipment for emergency drainage ready.
- Escalate to ECMO referral for severe refractory hypoxaemic respiratory failure.
Drugs & doses
Poractant alfa (surfactant) 100–200 mg/kg intratracheal for significant parenchymal disease
Inhaled nitric oxide 20 ppm, weaned as tolerated, for associated PPHN
Benzylpenicillin 50 mg/kg IV 12-hourly plus gentamicin 5 mg/kg IV every 36 h (empirical sepsis cover)
Morphine 10–20 microgram/kg/hour IV infusion for sedation while ventilated
Dopamine 5–20 microgram/kg/min IV to support systemic BP in PPHN
Disposition
NICU admission with capacity for ventilation, iNO and air-leak drainage; early discussion with a surfactant/ECMO centre for severe or refractory disease.
Complications & pitfalls
- Pneumothorax and other air leaks
- Persistent pulmonary hypertension of the newborn
- Surfactant inactivation and secondary pneumonia
- Chronic lung changes after severe disease
- Hypoxic-ischaemic injury from severe hypoxaemia
- Air trapping and ventilator-associated injury
Exam pearls
- Routine intrapartum and delivery-room suctioning of meconium is no longer recommended – ventilation comes first.
- A sudden deterioration in a ventilated MAS baby is a pneumothorax until proven otherwise.
- PPHN frequently coexists – obtain pre/post-ductal saturations early.
- Use lung-protective ventilation given the high air-leak risk.
- Antibiotics are reasonable because pneumonia and MAS are clinically indistinguishable early.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.